9/29/2020TYVYT and BYVASDA Combo Study Meets Its Primary Endpoints

9/29/2020Apollomics Granted Chinese IND Approval for APL-106 in Acute Myeloid L...

9/29/2020Beijing Court Rules Over Shareholder In-fighting of Sinovac (Free)

9/28/2020Polyphor Closes Exclusive Licensing Deal with Fosun for Balixafortide ...

9/28/2020AI Drug R&D Startup XtalPi Announces Over 300M Series C Investment

9/28/2020NMPA Issues the Registration Classification and Dossier Requirements o...

9/28/2020China Resources Pharma Agrees to Acquire Plasma Company Boya Biopharma

9/27/2020CPA Initiates Platform to Prepare for Medical Representative Registrat...

9/25/2020Performance Review of A Share-Listed Chinese MedPharm Companies in the...

9/25/2020IQVIA: China Represents 11% of Global Vaccine Market

9/25/2020Review of Chinese Pharma Licensing Trends 2015-2019

More>>

9/22/2020NMPA Proposes Implementing Rules on Patent Linkage for Public Comments

9/18/2020NMPA and CNIPA issue Draft Patent Linkage Measures in China

9/17/2020China's Draft Patent Linkage Implementation Measures for Public Commen...

9/16/2020Chinese Consumers Increasingly Prioritize Immune Health

9/15/2020Anheart Builds Its Oncology Pipeline Following Five Rs

9/15/2020With U.S.-China Relations Tremulous, Is China Still a Good Place to Do...

9/9/2020China Debates Cutting US Access to Drugs as Hostilities Spike

9/3/2020China Tightens Technology Export Control Rules

9/2/2020As MNCs Refocus on Innovative Drugs, Feel the Pulse of China's IP Land...

9/1/2020China's Pre-Revenue Biopharma Players Continue To Be Embraced By Marke...

8/30/2020McKinsey Report: Managing China's Growing Oncology Burden

More>>